EE523 Costs Per Responder With Venetoclax in Combination With Azacitidine in Unfit Patients With Previously Untreated Acute Myeloid Leukemia in China
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.2286
https://www.valueinhealthjournal.com/article/S1098-3015(24)02500-2/fulltext
Section Title :
Section Order :
10275
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02500-2&doi=10.1016/j.jval.2024.03.2286